Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest healthcare issue worldwide. This study aimed to develop a monoclonal antibody against SARS-CoV-2 from B cells of recovered COVID-19 patients, which might have beneficial therapeutic purposes for COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonkrai, Chatikorn, Cotrone, Thomas S., Chaisuriyong, Watchadaporn, Tantawichien, Terapong, Thisyakorn, Usa, Fernandez, Stefan, Hunsawong, Taweewun, Reed, Matthew, Wongtangprasert, Tossapon, Audomsun, Thittaya, Phakham, Tanapati, Attakitbancha, Chadaporn, Saelao, Pijitra, Focht, Dorota, Kimbung, Raymond, Welin, Martin, Malik, Aijaz Ahmad, Pisitkun, Trairak, Srisawat, Nattachai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159178/
https://www.ncbi.nlm.nih.gov/pubmed/37141227
http://dx.doi.org/10.1371/journal.pone.0284173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159178/
https://www.ncbi.nlm.nih.gov/pubmed/37141227
http://dx.doi.org/10.1371/journal.pone.0284173

Ejemplares similares